by admin | Feb 21, 2022 | News
BiOrion Technologies BV has raised additional funding from one of its founders for a clinical phase 2 diagnostic-imaging program in cardiac fibrosis patients. BiOrion Technologies BV (BiOrion), a biopharmaceutical drug discovery company, develops products for...
by admin | Jan 27, 2022 | Positions
Job description: Intern Life SciencesType: 80% – 100%, dependent on requirements training programLocation: Groningen The NetherlandsDate: Immediate About the role At BiOrion we are able to support up to 2 internships simultaneously. The Intern at BiOrion works...
by admin | Jan 21, 2022 | Positions
Job description: VP Business Development Type: 20% – 60%, on management contractLocation: Groningen The NetherlandsDate: Immediate About the role The VP Business Development is responsible for managing and developing BiOrion’s business development...
by admin | Sep 30, 2020 | News
BiOrion Technologies announced today that a first fibrosis patient has been enrolled in the first-in-human PET imaging study with 68-Gallium labeled PDGF beta receptor binding bicyclic peptide BOT5035. Herman Steen, CEO of BiOrion, “The enrollment of the first patient...